Skip to main content
Caplight Logo









SignalChem Lifesciences Corporation

SignalChem Lifesciences Corporation

Private
Richmond, British ColumbiaHealthcare & Life Scienceshttps://signalchemlifesciences.com/

Last Round

Strategic

Sep 24, 2021

Total Funding Raised

$13M

Company Overview

SignalChem Lifesciences Corporation is a biotechnology company that develops novel small-molecule targeted therapies for the treatment of cancer, inflammation, and central nervous system diseases.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Clinical Trials

Business Model

B2B

Customer Profile

Services & Consulting, Data as a Service

AI Layer

Non-AI

Keywords

biotechnologydrug discoverykinase inhibitorsoncologysmall-molecule therapytargeted therapyclinical-stage biotechdrug developmenttherapeutic resistancebioinformaticsmedicinal chemistrydrug pipelinebiotech startuppharma licensingdrug discovery platform

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

SignalChem Lifesciences Corporation Comparables

Compare SignalChem Lifesciences Corporation with similar companies based on industry and business-model similarity.

SignalChem Lifesciences Corporation comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
BerGenBio ASA
82%
Pacylex Pharmaceuticals
79%
Carna Biosciences, Inc.
78%

SignalChem Lifesciences Corporation Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
StrategicSep 24, 2021

Key People

Founding team and executive leadership

Jun Yan

CEO and President

Executive Team

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jan 22, 2026

    Monthly visitors increased 282% MoM.

  • Oct 30, 2024

    Monthly visitors grew 69% MoM, from 501 to 847.

SignalChem Lifesciences Corporation Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

SignalChem Lifesciences Corporation Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about SignalChem Lifesciences Corporation's valuation, stock price, and market status.

Firmographic Details

HeadquartersRichmond, British Columbia
Employee Range18
Year Founded2012
Last FundingSep 24, 2021

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?